OverviewChartNewsTraderScreen

Galera Therapeutics/  US36338D1081  /

IEX
2024-05-10  9:54:15 PM Chg. 0.00 Volume Bid- Ask- High Low
0.18USD -1.30% 37,961
Turnover: 6,565.08		 -Bid Size: - -Ask Size: - 0.18 0.16
GlobeNewswire 05-03 Galera Adopts Limited Duration Stockholder Rights Agreement
GlobeNewswire 04-16 Nacuity Pharmaceuticals Expands Board of Directors with Appointment of Dr. Emmett Cunningham, Jr.
GlobeNewswire 03-28 Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates
GlobeNewswire 2023-11-14 Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates
GlobeNewswire 2023-10-31 Galera Announces Receipt of Type A Meeting Minutes and Strategic Update
GlobeNewswire 2023-09-18 Galera Schedules Type A Meeting with FDA to Discuss Next Steps for Avasopasem
GlobeNewswire 2023-09-05 Galera to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
GlobeNewswire 2022-03-10 Galera Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Updates
GlobeNewswire 2022-01-05 Context Therapeutics® Strengthens Research & Development Team
GlobeNewswire 2021-12-14 Galera Announces Primary Endpoint Met Statistical Significance in Corrected Topline Efficacy Data of...
GlobeNewswire 2021-11-15 Galera to Present at Two Upcoming Investor Conferences in November
GlobeNewswire 2021-11-10 Galera Reports Third Quarter 2021 Financial Results and Recent Corporate Updates
GlobeNewswire 2021-10-19 Galera Announces Results of Phase 3 ROMAN Trial of Avasopasem for Radiotherapy-Induced Severe Oral M...
GlobeNewswire 2021-10-12 Galera Appoints Mark J. Bachleda as Chief Commercial Officer and Jennifer Evans Stacey as Chief Lega...
GlobeNewswire 2021-09-14 Galera to Host Virtual Key Opinion Leader Event on Radiotherapy-Induced Severe Oral Mucositis (SOM) ...
GlobeNewswire 2021-09-08 Galera Announces Final Results from Pancreatic Cancer Trial Showing Improvements on all Efficacy Par...
GlobeNewswire 2021-09-07 Galera to Present at Three Upcoming Investor Conferences in September
GlobeNewswire 2021-08-10 Galera Reports Second Quarter 2021 Financial Results and Recent Accomplishments
GlobeNewswire 2021-06-28 Galera Announces Completion of Enrollment in Pivotal 455-Patient Phase 3 Trial of Avasopasem for Sev...
GlobeNewswire 2021-05-26 Galera to Present at the Jefferies Virtual Healthcare Conference
GlobeNewswire 2021-05-17 Galera Announces First Patient Dosed with GC4711 in Phase 2b GRECO-2 Trial in Patients with Pancreat...
GlobeNewswire 2021-05-12 Science Translational Medicine Article Shows Galera’s Selective Dismutase Mimetic Synergizes with Ra...
GlobeNewswire 2021-05-11 Galera Reports First Quarter 2021 Financial Results and Recent Accomplishments
GlobeNewswire 2021-05-05 Galera to Participate in the BofA Securities 2021 Virtual Healthcare Conference
GlobeNewswire 2021-04-28 Galera Announces Updated Data from its Randomized, Multicenter, Placebo-Controlled Trial in Patients...